These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 20695361

  • 1. [Inhaled corticosteroids in COPD and the risk of pneumonia].
    Niţu M, Medregoniu D, Olteanu M, Golli A, Olteanu M, Măceşeanu A, Medregoniu R.
    Pneumologia; 2010; 59(2):74-6. PubMed ID: 20695361
    [Abstract] [Full Text] [Related]

  • 2. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
    Singh S, Amin AV, Loke YK.
    Arch Intern Med; 2009 Feb 09; 169(3):219-29. PubMed ID: 19204211
    [Abstract] [Full Text] [Related]

  • 3. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 09; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 4. Inhaled corticosteroids and pneumonia in COPD: an association looking for evidence.
    Turner MO.
    Am J Respir Crit Care Med; 2008 Mar 01; 177(5):555-6; author reply 556. PubMed ID: 18296470
    [No Abstract] [Full Text] [Related]

  • 5. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.
    Ernst P, Gonzalez AV, Brassard P, Suissa S.
    Am J Respir Crit Care Med; 2007 Jul 15; 176(2):162-6. PubMed ID: 17400730
    [Abstract] [Full Text] [Related]

  • 6. Inhaled corticosteroids and risk of pneumonia: evidence for and against the proposed association.
    Singanayagam A, Chalmers JD, Hill AT.
    QJM; 2010 Jun 15; 103(6):379-85. PubMed ID: 20231237
    [Abstract] [Full Text] [Related]

  • 7. [Inhaled corticosteroids in COPD--between pro and con?].
    Mihalţan F.
    Pneumologia; 2009 Jun 15; 58(4):204-5. PubMed ID: 20067052
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug 15; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 9. Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia.
    Liapikou A, Toumbis M, Torres A.
    Expert Opin Drug Saf; 2015 Aug 15; 14(8):1237-47. PubMed ID: 26113207
    [Abstract] [Full Text] [Related]

  • 10. Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD).
    Med Lett Drugs Ther; 2010 May 31; 52(1339):41-2. PubMed ID: 20508579
    [No Abstract] [Full Text] [Related]

  • 11. [Risk of pneumonia during long term regular treatment of stable COPD with inhaled glucocorticoids: a systematic review.].
    Arpinelli F, Caramori G, Magnoni MS.
    Recenti Prog Med; 2017 Apr 31; 108(4):175-182. PubMed ID: 28492586
    [Abstract] [Full Text] [Related]

  • 12. Inhaled corticosteroids and fracture risk in COPD.
    Suissa S, Ernst P.
    Am J Respir Crit Care Med; 2004 Jul 01; 170(1):94; author reply 94-5. PubMed ID: 15220123
    [No Abstract] [Full Text] [Related]

  • 13. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!].
    Rochat T.
    Rev Med Suisse; 2008 Jan 16; 4(140):155-7. PubMed ID: 18309880
    [Abstract] [Full Text] [Related]

  • 14. Clinical inquiries. What effect do inhaled steroids have on delaying the progression of COPD?
    Hansen L, Havemann J, Burroughs M, Lo V.
    J Fam Pract; 2004 Oct 16; 53(10):835-6. PubMed ID: 15469782
    [No Abstract] [Full Text] [Related]

  • 15. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ, Au DH, Fitzgibbon ML, Lee TA.
    Respir Med; 2010 Feb 16; 104(2):246-52. PubMed ID: 19879745
    [Abstract] [Full Text] [Related]

  • 16. Inhaled corticosteroids in COPD.
    Bedi RS.
    Indian J Chest Dis Allied Sci; 2005 Feb 16; 47(4):243-4. PubMed ID: 16255394
    [No Abstract] [Full Text] [Related]

  • 17. The risk and outcomes of pneumonia in patients on inhaled corticosteroids.
    Sibila O, Soto-Gomez N, Restrepo MI.
    Pulm Pharmacol Ther; 2015 Jun 16; 32():130-6. PubMed ID: 25956073
    [Abstract] [Full Text] [Related]

  • 18. Do inhaled corticosteroids slow FEV1 decline in COPD after all?
    Duerden MG.
    Thorax; 2004 Jun 16; 59(6):538-9; author reply 539-40. PubMed ID: 15170045
    [No Abstract] [Full Text] [Related]

  • 19. [Do inhaled corticosteroids reduce mortality in chronic obstructive pulmonary disease?].
    Bridevaux PO, Leuenberger P.
    Rev Med Suisse; 2005 Nov 16; 1(41):2673-4, 2677-9. PubMed ID: 16355882
    [Abstract] [Full Text] [Related]

  • 20. Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.
    Bourbeau J, Aaron SD, Barnes NC, Davis KJ, Lacasse Y, Nadeau G.
    Respir Med; 2017 Feb 16; 123():94-97. PubMed ID: 28137503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.